Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipients

Omission of in vivo T-cell depletion promotes rapid expansion of naïve CD4+ cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant

(2012) Robert Chiesa et al.   BRITISH JOURNAL OF HAEMATOLOGY

Efficacy and safety of low-dose ganciclovir preemptive therapy in allogeneic haematopoietic stem cell transplant recipients compared with conventional-dose ganciclovir: a prospective observational study

(2012) So-Youn Park et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Cytomegalovirus Viral Load and Virus-Specific Immune Reconstitution after Peripheral Blood Stem Cell versus Bone Marrow Transplantation

(2011) Abraham Guerrero et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Pre-emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein-Barr virus-associated lymphoproliferative disease following stem cell transplantation

(2011) Austen Worth et al.   BRITISH JOURNAL OF HAEMATOLOGY

How I treat adenovirus in hematopoietic stem cell transplant recipients

(2010) C. A. Lindemans et al.   BLOOD

Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation

(2010) K. S. Peggs et al.   CLINICAL INFECTIOUS DISEASES

Incidence and Dynamics of Epstein-Barr Virus Reactivation After Alemtuzumab-Based Conditioning for Allogeneic Hematopoietic Stem-Cell Transplantation

(2010) Ben Carpenter et al.   TRANSPLANTATION

Defining the Intensity of Conditioning Regimens: Working Definitions

(2009) Andrea Bacigalupo et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

(2009) A. M. Leen et al.   BLOOD

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

(2009) H. E. Heslop et al.   BLOOD

T-cell Lines Specific for Peptides of Adenovirus Hexon Protein and Devoid of Alloreactivity Against Recipient Cells can be Obtained From HLA-haploidentical Donors

(2009) Patrizia Comoli et al.   JOURNAL OF IMMUNOTHERAPY